首页> Trials> Correction: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE).

Correction: Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE).

导出 OA

翻译打印收藏纠错

第一作者： Tania A,Smith

第一单位： CINVESTAV-IPN, Mexico, Mexico. tania.smith@cinvestav.mx.

作者： Tania A,Smith ^[1] ; Carlos,Hoyo-Vadillo ^[2] ; Akosua Agyeman,Adom ^[3] ; Liliana,Favari-Perozzi ^[2] ; Silke,Gastine ^[3] ; Hakim-Moulay,Dehbi ^[4] ; Beatriz,Villegas-Lara ^[5] ; Eduardo,Mateos ^[5] ; Yessica Sara Pérez,González ^[5] ; Maria D,Navarro-Gualito ^[5] ; Alejandra S,Cruz-Carbajal ^[5] ; Miguel A,Cortes-Vazquez ^[5] ; Carolina,Bekker-Méndez ^[5] ; Charmina,Aguirre-Alvarado ^[5] ; Gisela,Aguirre-Gil ^[6] ; Lucero,Delgado-Pastelin ^[6] ; Andrew,Owen ^[7] ; David,Lowe ^[8] ; Joseph,Standing ^[3] ; Jorge,Escobedo ^[5]

作者单位： CINVESTAV-IPN, Mexico, Mexico. tania.smith@cinvestav.mx. ^[1] CINVESTAV-IPN, Mexico, Mexico. ^[2] ICH-UCL, London, UK. ^[3] Clinical Trials Unit, UCL, London, UK. ^[4] IMSS, Mexico, Mexico. ^[5] Hakken Enterprise, Cuernavaca, Mexico. ^[6] University of Liverpool, Liverpool, UK. ^[7] Division of Infection and Immunity, UCL, London, UK. ^[8]

DOI 10.1186/s13063-023-07364-3

PMID 37218017

发布时间 2025-05-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交